Healthcare is undergoing a major transformation. Treatments that once required regular hospital visits are increasingly moving into patients’ homes, allowing people to receive care in a more comfortable and convenient environment. This shift has created a growing demand for technologies that make treatment safer, easier, and more reliable outside traditional healthcare settings. Smart drug delivery systems have emerged as one of the most important innovations supporting this change.
Among the companies helping drive this evolution is Eitan Medical, an Israel-based medical technology company focused on infusion therapy and advanced drug delivery solutions. Through innovative platforms designed for hospitals, ambulatory care, and home treatment, Eitan Medical has worked to improve how patients receive medications while helping healthcare providers maintain high standards of care.
The company’s commitment to patient-centered innovation has led to the development of technologies that simplify complex treatments and support the growing movement toward home-based healthcare. One of its most recognized innovations is the Sorrel™ wearable drug delivery platform, a technology designed to make the administration of biologic medicines more convenient for patients while maintaining safety and effectiveness.
The Growing Importance of Smart Drug Delivery Systems
Modern medicine has changed dramatically over the last two decades. Pharmaceutical companies now develop increasingly sophisticated therapies, particularly biologic drugs used to treat conditions such as cancer, autoimmune diseases, and rare disorders. While these treatments have improved patient outcomes, many require careful administration and monitoring.
Traditional delivery methods often require patients to visit hospitals or infusion centers regularly. These visits can be time-consuming, expensive, and physically demanding, especially for individuals managing long-term illnesses. Smart drug delivery systems address these challenges by combining medical devices with advanced technology. These systems help ensure medications are delivered accurately and safely while reducing the burden on patients and healthcare providers. Features such as automated delivery controls, safety mechanisms, monitoring capabilities, and intuitive user interfaces allow patients to manage treatments with greater confidence.
As healthcare providers continue expanding home-based care programs, the need for reliable drug delivery technologies has become increasingly important. This is where companies like Eitan Medical have found an opportunity to make a meaningful impact.
Eitan Medical’s Mission to Improve Patient Care
Eitan Medical focuses on creating infusion and drug delivery solutions that put patients at the center of the healthcare experience. The company’s goal is not simply to deliver medication but to improve the overall treatment journey for patients, caregivers, clinicians, and healthcare organizations.
The company develops technologies that prioritize ease of use, reliability, and safety. By designing systems that simplify treatment processes, Eitan Medical helps reduce the challenges patients often face when managing therapies outside clinical settings.
Its products serve a wide range of healthcare environments, including hospitals, infusion centers, ambulatory care facilities, emergency medical services, and home healthcare programs. This broad reach reflects the company’s understanding that patient needs can vary significantly depending on where treatment takes place. Rather than creating solutions for a single setting, Eitan Medical has built a portfolio that supports care across the entire treatment continuum.
The Sorrel™ Wearable Drug Delivery Platform
One of the company’s most significant contributions to smart drug delivery is the Sorrel™ wearable drug delivery platform. The Sorrel™ platform was developed to support the growing use of biologic medicines that often require larger injection volumes than conventional drugs. Many of these therapies are highly effective but can be difficult to administer using traditional methods.
Eitan Medical designed Sorrel™ as a wearable, on-body injector that enables patients to self-administer medication through subcutaneous delivery. The platform helps simplify treatment by allowing patients to receive medication at home rather than making frequent trips to healthcare facilities. The design focuses heavily on patient convenience. Patients can wear the device on their body while medication is delivered over a controlled period. This approach helps improve comfort and can reduce disruption to daily activities.
The platform also incorporates advanced safety features. Smart sensors monitor the delivery process and help ensure the medication is administered correctly. The device uses patented ultraviolet technology that supports sterility throughout the fluid path, an important factor in maintaining patient safety.
Another notable advantage of the Sorrel™ platform is its flexibility. It is designed to accommodate different primary containers, allowing pharmaceutical companies to integrate their therapies without major modifications. The platform supports both vial and cartridge configurations and can handle a range of medication volumes. This flexibility makes the technology attractive to pharmaceutical partners developing next-generation biologic therapies.
Industry Recognition for Innovation
The pharmaceutical and medical technology industries have recognized the innovation behind the Sorrel™ platform. In 2021, Eitan Medical received the Excellence in Pharma: Packaging & Drug Delivery Award at the CPhI Pharma Awards. The award acknowledged the company’s efforts to develop a patient-focused solution that addresses challenges associated with home treatment.
The recognition highlighted how wearable drug delivery technology can help improve medication adherence while making treatment more accessible and convenient for patients. Receiving recognition from one of the pharmaceutical industry’s major award programs reinforced Eitan Medical’s position as an innovator in advanced drug delivery technology.
A Significant Business Milestone
A major development in the company’s history occurred in 2023 when Eitan Medical completed the sale of its Sorrel wearable drug delivery device business to LTS, also known as Lohmann Therapie-Systeme AG, a pharmaceutical technology company based in Germany.
The acquisition represented an important strategic step for both organizations. For LTS, the transaction expanded its capabilities in drug delivery technologies and strengthened its position in the growing biologics market.
The deal also demonstrated the value and commercial potential of the Sorrel™ platform. The technology had attracted significant interest because of its ability to support large-volume biologic therapies through a patient-friendly wearable format. Following the acquisition, the Sorrel business continued its development under LTS, ensuring that the technology could continue advancing within a company focused on pharmaceutical delivery solutions.
Eitan Medical’s Journey Through Innovation
Eitan Medical’s story began in 1996 when the company was established under the name Q-Core. From its early years, the organization focused on developing technologies that could improve medication delivery and infusion therapy. Over time, the company expanded its capabilities and broadened its reach into international healthcare markets. Through continuous investment in product development and innovation, it evolved into a recognized provider of infusion and drug delivery solutions.
Today, Eitan Medical serves healthcare providers and patients across multiple regions worldwide. Its technologies support treatment delivery in diverse environments, from hospitals and specialty clinics to patients’ homes. The company’s growth reflects a long-term commitment to solving practical healthcare challenges through engineering, innovation, and user-centered design.
CEO Shaul Eitan and His Contribution to Eitan Medical
Leadership has played an important role in Eitan Medical’s development, and Shaul Eitan has been a key figure in the company’s journey. Shaul Eitan serves as the Chief Executive Officer of Eitan Medical. Before assuming the CEO position, he spent many years working across different areas of the business, gaining extensive experience in operations, product development, marketing, and corporate leadership.
His educational background includes a Bachelor of Science degree in Electrical Engineering from Tel Aviv University. The technical knowledge gained through his engineering education provided a strong foundation for a career focused on medical technology and innovation. Throughout his career at Eitan Medical and its predecessor organization, Shaul Eitan held several leadership positions. These roles allowed him to develop a deep understanding of the company’s products, customers, manufacturing processes, and long-term strategy.
His contributions have extended beyond day-to-day management. By helping oversee operational growth and supporting the development of the company’s infusion and drug delivery technologies, he has played a role in strengthening Eitan Medical’s position within the healthcare technology industry. His combination of engineering expertise and operational leadership has helped guide the company through periods of growth and strategic change. Under his leadership, Eitan Medical continues to focus on innovation while maintaining its commitment to patient-centered care.
Building Solutions Beyond Wearable Drug Delivery
Although the Sorrel™ platform gained significant attention, it represents only one part of Eitan Medical’s broader portfolio. The company also developed the Sapphire™ infusion platform, which serves hospital and ambulatory care environments. The platform supports multiple therapy types and incorporates technology designed to improve safety and simplify clinical workflows. Healthcare professionals use Sapphire™ systems to deliver medications accurately while benefiting from features that support efficient treatment administration.
Another important solution is the Avoset™ connected infusion system. Designed specifically for home care, Avoset™ simplifies infusion therapy for patients who need treatment outside traditional healthcare settings. The system enables healthcare teams to monitor treatment progress while helping patients follow prescribed therapy plans. By combining ease of use with connectivity, Avoset™ supports better communication between patients and care providers.
Together, these technologies demonstrate Eitan Medical’s commitment to supporting healthcare across different care settings rather than focusing on a single treatment environment.
Supporting the Shift Toward Home-Based Healthcare
The global healthcare industry continues moving toward care models that emphasize convenience, accessibility, and patient independence. Advances in digital health, connected medical devices, and remote monitoring technologies are accelerating this transition. Patients increasingly prefer receiving treatment at home whenever possible. Home-based care can improve comfort, reduce travel burdens, and help individuals maintain normal daily routines.
However, successful home treatment depends on technologies that patients can use safely and confidently. Smart drug delivery systems play a critical role in making this possible. Eitan Medical’s solutions help bridge the gap between clinical care and home treatment. By creating devices that combine advanced technology with intuitive design, the company supports safer medication administration outside traditional healthcare facilities.
This approach aligns with broader healthcare trends that emphasize patient empowerment and personalized care experiences.
Driving the Next Generation of Healthcare
The demand for advanced drug delivery technologies is expected to grow as more biologic therapies enter the market and healthcare systems continue expanding home-based treatment programs. Companies that can simplify treatment while maintaining safety and effectiveness will play an increasingly important role in the future of healthcare. Eitan Medical has built its reputation by addressing these challenges through innovation and patient-focused design. From wearable injectors and connected infusion systems to hospital-based therapy platforms, the company continues developing solutions that support modern healthcare delivery.
Its work demonstrates how technology can improve the patient experience while helping healthcare providers deliver high-quality care across multiple treatment settings. Smart drug delivery systems are transforming how patients receive medications and manage long-term treatments. By reducing complexity and supporting greater independence, these technologies are helping reshape healthcare around the needs of patients.
Eitan Medical has emerged as an important contributor to this transformation through its commitment to innovation, safety, and patient-centered design. The company’s Sorrel™ wearable drug delivery platform, along with its broader infusion technology portfolio, highlights the potential of smart healthcare solutions to improve treatment experiences and outcomes. As the healthcare industry continues evolving, Eitan Medical’s focus on making drug delivery simpler, safer, and more accessible positions it to remain an influential player in the advancement of modern healthcare technology.
